Sporadic hemiplegic Migraine

Current Pain and Headache Reports

Volumn 8, Issue 3, 2004, Pages 223-228

  Black, David F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIHYDROERGOTAMINE; ERGOTAMINE TARTRATE; FUROSEMIDE; KETAMINE; MAGNESIUM; NALOXONE; PHENYTOIN; PROCHLORPERAZINE; PROPRANOLOL; VASOCONSTRICTOR AGENT; VERAPAMIL;

ANAMNESIS; ANESTHESIA; APHASIA; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; DATA ANALYSIS; DEMOGRAPHY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HEADACHE; HEMIANOPIA; HEMIPLEGIA; HUMAN; LABORATORY TEST; MALE; MEDICAL DECISION MAKING; MIGRAINE; MUSCLE WEAKNESS; NAUSEA AND VOMITING; NEUROIMAGING; PARESTHESIA; PATHOPHYSIOLOGY; PHOTOPHOBIA; PHYSICAL EXAMINATION; PREVALENCE; REMISSION; REVIEW; SCOTOMA; SYMPTOMATOLOGY; TREATMENT PLANNING;

EID: 3142662554     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-004-0056-2     Document Type: Review

References (48)

1. Liveing E: On Megrim, Sick-Headache, and Some Allied Disorders. London: Churchill; 1873.
2. Whitty CW: Familial hemiplegic migraine. J Neurol Neurosurg Psychiatry 1953, 16:172-177.
3. Headache Classification Committee of the International Headache Society: The international classification of headache disorders. Cephalalgia 2004, 24:29.
4. Thomsen LL, Ostergaard E, Olesen J, Russell MB: Evidence for a separate type of migraine with aura. Neurology 2003, 60:595-601.
5. Terwindt G, Kors E, Haan J, et al.: Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. Arch Neurol 2002, 59:1016-1018.
6. Thomsen LL, Eriksen MK, Romer SF, et al.: An epidemiological survey of hemiplegic migraine. Cephalalgia 2002, 22:361-375.
7. Bradshaw P, Parsons M: Hemiplegic migraine: a clinical study. Q J Med 1965, 34:65-86.
8. Razavi M, Razavi B, Fattal D, et al.: Hemiplegic migraine induced by exertion. Arch Neurol 2000, 57:1363-1365.
9. Kors EE, Terwindt GM, Vermeulen FL, et al.: Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol 2001, 49:753-760.
10. Black DF, Swanson JW: Familial hemiplegic migraine and Erdheim-Chester disease [Abstract]. Headache 2002, 42:460-461.
11. Hayashi R, Tachikawa H, Watanabe R, et al.: Familial hemiplegic migraine with irreversible brain damage. Intern Med 1998, 37:166-168.
12. Wada T, Kobayashi N, Takahashi Y, et al.: Wide clinical variability in a family with a CACNA1A T666M mutation: hemiplegic migraine, coma, and progressive ataxia. Pediatr Neurol 2002, 26:47-50.
13. Carrera P, Piatti M, Stenirri S, et al.: Genetic heterogeneity in Italian families with familial hemiplegic migraine. Neurology 1999, 53:26-33.
14. Ophoff RA, Terwindt GM, Vergouwe MN, et al.: Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996, 87:543-552.
15. Ducros A, Denier C, Joutel A, et al.: The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001, 345:17-24.
16. Berg MJ, Williams LS: The transient syndrome of headache with neurologic deficits and CSF lymphocytosis. Neurology 1995, 45:1648-1654.
17. Parikh S, Swaiman KF, Kim Y: Neurologic characteristics of childhood lupus erythematosus. Pediatr Neurol 1995, 13:198-201.
18. Seleznick MJ, Silveira LH, Espinoza LR: Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol 1991, 18:1416-1417.
19. Bartleson JD, Krecke KN, O'Neill BP, Brown PD: Reversible, stroke-like migraine attacks in patients with previous radiation therapy. Neuro-oncol, 2003, 2:121-127.
20. Koo B, Becker L, Chuang S, et al.: Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes (MELAS): clinical, radiological, pathological, and genetic observations. Ann Neurol 1993, 34:25-32.
21. Steele JG, Nath PU, Burn J, Porteous ME: An association between migrainous aura and hereditary hemorrhagic telangiectasia. Headache 1993, 33:145-148.
22. de Grauw TJ, Smit LM, Brockstedt M, et al.: Acute hemiparesis as the presenting sign in a heterozygote for ornithine transcarbamylase deficiency. Neuropediatrics 1990, 21:133-135.
23. Silva GS, Almeida CM, Felix EP, et al.: Cerebral venous thrombosis and homocystinuria: case report. Arq Neuropsiquiatr 2001, 59:815-816.
24. Dora B, Balkan S: Sporadic hemiplegic migraine and Sturge-Weber syndrome. Headache 2001, 41:209-210.
25. Yu W, Horowitz SH: Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology 2003, 60:120-121.
26. Fuentes B, Diez Tejedor E, Pascual J, et al.: Cerebral blood flow changes in pseudomigraine with pleocytosis analyzed by single photon emission computed tomography: A spreading depression mechanism? Cephalalgia 1998, 18:570-573.
27. DeBenedittis G, Ferrari DaPassano C, et al.: BF changes during headache-free periods and spontaneous/induced attacks in migraine with and without aura: a TCD and SPECT comparison study. J Neurosurg Sci 1999, 43:141-147.
28. Pascual J, Valle N. Pseudomigraine with lymphocytic pleocytosis. Curr Pain Headache Rep 2003, 7:224-228.
29. Vahedi K, Denier C, Ducros A, et al.: CACANA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. Neurology 2000, 55:1040-1042.
30. Chapman KM, Szczygielski BI, Toth C, et al.: Pseudomigraine with lymphocytic pleocytosis: A calcium channelopathy? Clinical description of 10 cases and genetic analysis of the familial hemiplegic migraine gene CACNA1A. Headache 2003, 43:892-895.
31. Arzimanoglou A, Aicardi J: The epilepsy of Sturge-Weber syndrome: clinical features and treatment in 23 patients. Acta Neurol Scand Suppl 1992, 140:18-22.
32. Ducros A, Denier C, Joutel A, et al.: Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am J Hum Genet 1999, 64:89-98.
33. De Fusco M, Marconi R, Silvestri L, et al.: Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump a2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003, 33:192-196.
34. Vanmolkot KR, Kors EE, Hottenga JJ, et al.: Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 2003, 54:360-366.
35. Ducros A, Joutel A, Vahedi K, et al.: Mapping of second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol 1997, 42:885-890.
36. Klapper J, Mathew N, Nett R: Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache 2001, 41:981-984.
37. Prendes JL: Consideration on use of propranolol in complicated migraine. Headache 1980, 20:93-95.
38. Gilbert GJ: An occurrence of complicated migraine during propranolol therapy. Headache 1982, 22:81-83.
39. Bardwell A, Trott J: Stroke in migraine as a consequence of propranolol. Headache 1987, 27:381-383.
40. Kaube H, Herzog J, Kaufer T, et al.: Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 2000, 55:139-141.
41. Rozen T: Treatment of a prolonged migrainous aura with intravenous furosemide. Neurology 2000, 55:732-733.
42. Rozen T: Aborting a prolonged migrainous aura with intravenous prochlorperazine and magnesium sulfate. Headache 2003, 43:901-903.
43. Centonze V, Brucoli C, Macinagrossa C, et al.: Non-familial hemiplegic migraine responsive to naloxone. Cephalalgia 1983, 3:125-127.
44. Lastimosa AC: Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology 2003, 61:721-722.
45. Dobrev D, Milde AS, Andreas K, Ravens U: The effects of verapamil and diltiazem on N, P- and Q-type channels mediating dopamine release in rat striatum. Br J Pharmacol 1999, 127:576-582.
46. Tricarico D, Barberi M, Camerino DC: Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis. Ann Neurol 2000, 48:304-312.
47. Athwal BS, Lennox GG: Acetazolamide responsiveness in familial hemiplegic migraine. Ann Neurol 1996, 40:820-821.
48. Battistini S, Stenirri S, Piatti M, et al.: A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 1999, 53:38-43.